Abingdon, United Kingdom

Edward Alexander McKenzie

This inventor holds 1 USPTO granted patent. Top assignee: Ucb Pharma, S.a.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward Alexander McKenzie. Retrieved from https://idiyas.com/inventor/edward-alexander-mckenzie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward Alexander McKenzie: Innovator in Heparanase-Like Polypeptides

Introduction

Edward Alexander McKenzie is a notable inventor based in Abingdon, GB. With a keen focus on biotechnology, he has developed innovative solutions that contribute to the understanding of heparanase and its implications in various medical applications.

Latest Patents

McKenzie holds a patent for heparanase-like polypeptides, which provides a homologue to heparanase that is present in three splice variants. This invention showcases significant advancements in the field of biomedical research and offers potential avenues for therapeutic interventions.

Career Highlights

McKenzie is currently associated with UCB Pharma S.A., a leading biopharmaceutical company that focuses on the development of innovative medicines. His contributions to the field of biotechnology through his role at UCB Pharma have paved the way for advancements in therapeutic applications.

Collaborations

Throughout his career, McKenzie has collaborated with esteemed colleagues, including Alasdair Stamps and Jonathan Alexander Terrett. Their collective expertise and efforts underscore the collaborative nature of innovation in the biopharmaceutical industry.

Conclusion

Edward Alexander McKenzie stands out as an accomplished inventor whose work in heparanase-like polypeptides marks a significant contribution to scientific research and biopharmaceutical innovation. His collaborations and ongoing projects continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…